Overview

The webinar will feature a pulmonologist and respiratory therapist who will explore the role of RRTs in identifying misdiagnosed or at-risk patients with Chronic-Fibrosing Interstitial Lung Disease (CF-ILD), discuss pulmonary function monitoring, and examine patient needs to maximize QoL through comprehensive care plans with the help of a Pulmonary Fibrosis Foundation (PFF) patient advocate. 

This educational activity is designed for respiratory therapists and other clinicians involved in the management of patients with CF-ILD.

Registered Respiratory Therapists (RRT) need continuing education to better assist in identifying misdiagnosed or at-risk patients with CF-ILD, monitoring and assessing current patients with CF-ILD, and providing specialist referral.  RRTs also need continuing education in identifying comorbid conditions (including psychosocial issues), addressing palliative care concerns (e.g. stigma with oxygen use), and providing an environment for socialization with other patients struggling with similar pulmonary limitations.  

Upon completion of this activity, participants will be able to:
• Describe the identification of chronic fibrosing interstitial lung disease (CF-ILD) across disease entities
• Discuss the impact of CF-ILD on patient quality of life
• Outline pharmacologic and respiratory therapy interventions that can assist patients with CF-ILD

Sponsored by the Academy for Continued Healthcare Learning

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.